Patents for C12R 1 - Micro-organisms (92,025) |
---|
07/08/1997 | US5646037 Novel hybrid vectors based on yeast two micron plasmid;expression of heterologous genes |
07/08/1997 | US5646029 Genetically engineered replacement for products derived from plant gums such as guar and gum arabic |
07/08/1997 | US5646024 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants |
07/08/1997 | US5646014 Peptide, antibacterial agent, peptide gene, recombinant DNA and method for preparing the peptide |
07/08/1997 | US5646011 Overcoming resistance of tumor cells to chemotheraputic agents, gene expression |
07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
07/08/1997 | US5645999 Assays for compounds that modulate or alter cyclin E activity |
07/08/1997 | US5645984 Process for depleting viruses in solutions and determining their depletion rate |
07/08/1997 | US5645835 Therapeutic antibody based fusion proteins |
07/08/1997 | US5645833 Inhibitor resistant serine proteases |
07/08/1997 | US5645832 Use of lipases for producing drugs |
07/08/1997 | US5645829 Mesothelial cell gene therapy |
07/08/1997 | US5645817 Granulocyte-binding antibody constructs, their preparation and use |
07/08/1997 | CA2127878C Fo-1289 substance and its production |
07/05/1997 | CA2194411A1 Staphylococcus aureus polynucleotides and sequences |
07/03/1997 | WO1997023683A1 Use of xyloglucan endotransglycosylase (xet) |
07/03/1997 | WO1997023633A1 Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods |
07/03/1997 | WO1997023630A2 Polyketide-associated sugar biosynthesis genes |
07/03/1997 | WO1997023628A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
07/03/1997 | WO1997023623A1 Component of a staphylococcus signal transduction system |
07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
07/03/1997 | WO1997023621A1 Component of a staphylococcus signal transduction system |
07/03/1997 | WO1997023615A1 Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof |
07/03/1997 | WO1997023614A1 Osteoprotegerin |
07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
07/03/1997 | WO1997023597A2 Process for the microbial production of amino acids by boosted activity of export carriers |
07/03/1997 | WO1997023509A1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
07/03/1997 | WO1997023506A1 Two-component signal tranducing system from staphylococcus aureus |
07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
07/03/1997 | WO1997023129A1 Model transgenic animal for interleukin-1 relevant diseases |
07/03/1997 | CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
07/02/1997 | EP0781843A1 Novel strain of the yeast candida sake (saito and ota) van uden and buckley and its use as biological control agent in fungal diseases of postharversted fruits |
07/02/1997 | EP0781348A1 Process for manufacturing cyclosporin a by highly productive fusant strain |
07/02/1997 | EP0781347A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
07/02/1997 | EP0781341A1 Method for the production of recombinant proteins, plasmids and modified cells |
07/02/1997 | EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
07/02/1997 | EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
07/02/1997 | EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
07/02/1997 | EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
07/02/1997 | EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
07/02/1997 | EP0781139A1 Intracellular delivery of chemical agents to a specific cell type |
07/02/1997 | EP0695345B1 MICROORGANISM OF GENUS $i(BACILLUS CEREUS) AND USE THEREOF |
07/02/1997 | EP0689552A4 A method of detecting rupture of the amniotic membranes in pregant mammals |
07/02/1997 | EP0627000A4 Mammalian expression systems for hcv proteins. |
07/02/1997 | EP0621871B1 A human kunitz-type protease inhibitor variant |
07/02/1997 | EP0592692B1 Fed batch process for protein secreting cells |
07/02/1997 | CN1153534A Microbial method |
07/02/1997 | CN1153533A Method for mass production of taxol by semi-continuous culture |
07/01/1997 | US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
07/01/1997 | US5644036 Purified immunoglobulin |
07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
07/01/1997 | US5644030 Gene and method for production of an IgA binding protein |
07/01/1997 | US5643871 Antitumor antibiotics |
07/01/1997 | US5643869 Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
07/01/1997 | US5643792 Mutant strain of Pichia pastoris which utilizes methanol in the presence of glucose |
07/01/1997 | US5643790 Genetic engineering with coryneform bacterium |
07/01/1997 | US5643775 Trehalose phosphorylase and preparation thereof |
07/01/1997 | US5643774 Dna molecules with polypeptides formed by biosynthesis |
07/01/1997 | US5643768 Cell-free synthesis and isolation of novel genes and polypeptides |
07/01/1997 | US5643759 Hybridoma cell lines |
07/01/1997 | US5643754 Nucleic acids encoding a leptospira outer membrane protein |
07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
07/01/1997 | US5643747 Gene expression and cloning of bordetella genome and dna sequences |
07/01/1997 | US5643745 Heterologous dimeric proteins produced in heterokaryons |
07/01/1997 | US5643736 Hybridomas and detection of osteogenic cell subsets |
07/01/1997 | US5643735 Anti-thymosin α1 monoclonal antibody-producing hybridoma |
07/01/1997 | US5643719 B-carotene |
07/01/1997 | US5643714 Method and assay for HTLV |
07/01/1997 | US5643578 Subunit vaccines |
07/01/1997 | US5643576 Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen |
07/01/1997 | US5643567 Antigrowth agents for tumors |
06/26/1997 | WO1997022711A1 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
06/26/1997 | WO1997022705A1 A FUNGUNS WHEREIN THE areA, pepC AND/OR pepE GENES HAVE BEEN INACTIVATED |
06/26/1997 | WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
06/26/1997 | WO1997022688A1 Heterophil-adapted poultry vaccine |
06/26/1997 | WO1997022686A1 Fungal food |
06/26/1997 | WO1997022654A1 Polyester particles |
06/26/1997 | WO1997022617A1 Methods for identifying compounds that bind to a target |
06/26/1997 | WO1997022564A1 Methods for improved rheological control in cementitious systems |
06/26/1997 | WO1997013845A3 Phosphopantetheinyl transferases and uses thereof |
06/26/1997 | WO1997007225A3 High efficiency retroviral packaging system |
06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
06/26/1997 | DE19548222A1 Verfahren zur mikrobiellen Herstellung von Aminosäuren durch gesteigerte Aktivität von Exportcarriern Process for the microbial production of amino acids by increased activity of export carriers |
06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
06/26/1997 | DE19547933A1 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung Multimeric forms of IL-16, process for their preparation and use |
06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
06/26/1997 | CA2238995A1 Methods for identifying compounds that bind to a target |
06/25/1997 | EP0780473A2 Thermostable mutants of D-N-alpha-Carbamoylase |
06/25/1997 | EP0780471A2 Novel nitrilase gene |
06/25/1997 | EP0779930A1 Methods and compositions for inhibiting production of replication competent virus |
06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
06/25/1997 | EP0779922A2 Modified human c3 proteins |
06/25/1997 | EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
06/25/1997 | EP0779896A1 New process for the production of biologically active protein |
06/25/1997 | EP0693134B1 Arylalkanoic acid resolution |